IRS Investment Company
S'pore pulls in $932m of biomed investments
SINGAPORE has again proved to be a powerful investment magnet in the cutting-edge biomedical sciences industry, even though regional competition for these investments is heating up. The Republic pulled in $932 million in fixed-asset investments last year, up from $901 million in 2006, the Economic Development Board (EDB) said on Tuesday. The sector - a relatively new pillar of Singapore's economy - covers pharmaceuticals, including the development of new drugs, medical products such as heart stents, and medical equipment, among other things. Total business spending in the sector also grew to a record high of $245 million last year, surpassing 2006's $217.3 million. Despite the recent economic turmoil in global markets, Singapore continues to attract new facilities.
5 Reasons Why You are Missing the Boat if You�re not Considering Alternative Investments � Part II
In the first installment we discussed three primary benefits that alternative investments can provide to a 'traditional' investment portfolio or as a stand-alone investment. Today, we'll conclude with two more, and by the end of this you should be asking yourself, "where do I go from here?" Reason #4 - Transparency Imagine how your financial adviser would look at you if you told him you want him to arrange a meeting with the chief decision-maker at one of the mutual funds that manage your money. Given the time of year, he might be expecting you to follow-up with "April Fools!" What if you were serious though? The truth is that it is highly unlikely that you would ever be able to get a straight answer on the inner workings of a large mutual fund's investment strategy and would probably never get an opportunity to meet with the CEO or president.
Privacy Terms And Conditions Contact Us
|